- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03810391
Using Preoperative Anxiety Score to Determine the Total Dose of Butorphanol for Sedation
January 17, 2019 updated by: Yanchao Yang, Shengjing Hospital
Using Preoperative Anxiety Score to Determine the Total Dose of Butorphanol for Sedation in Patients Undergoing Lower Limb Orthopedic Procedures: A Randomized, Double-blind, Placebo-controlled Study
Orthopedic surgeries are considered to be discomfortable and the sense of fear and anxiety of patients who already have preoperative anxiety may be aggravated by intraoperative stimulation, which may contribute to postoperative complications.
Previous studies have found that high anxiety predicts increased sedative requirements.
Therefore, the investigators explored the relationship between anxiety and intraoperative butorphanol requirements and the investigators evaluated the specific sedative requirement which can keep satisfactory sedative state for patients by preoperative anxiety score
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
A total of one hundred and eighteen patients who were to undergoing lower limb orthopedic procedures with spinal anesthesia were selected,the Amsterdam preoperative anxiety and information scale was used to evaluated the degree of preoperative anxiety one day before the surgery.
Patients in preoperative anxiety group were randomly allocated to two groups: butorphanol group (Group A) and physiological saline group (Group B); Patients in non-preoperative anxiety group were also randomly allocated to two groups: butorphanol group (Group C) and physiological saline group (Group D).
In Group A and Group C, patients received an intravenous loading dose of 15ug/kg butorphanol 5 min before starting the surgery, then followed by infusion of 7.5ug/kg/h butorphanol and stopped infusion until the Ramsay sedation score reached 4 points, Group B and Group D received an infusion of the same volume of physiological saline.
The sedation scores were recorded 10 min after getting into the operation room and 5, 10, 15, 30min after infusion of butorphanol or physiological saline.
The duration when Ramsay sedation score reached 4 points in Group A and C, adverse events and post-operative visual analgesia scale scores were also recorded and compared.
Study Type
Interventional
Enrollment (Actual)
126
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Liao Ning
-
Shenyang, Liao Ning, China, 110004
- Shengjing Hospital of China Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- American Society of Anesthesiologists (ASA)Ⅰ-Ⅱ
- 18-75 years
- Scheduled for elective low limb orthopaedic procedures under spinal anesthesia
Exclusion Criteria:
- central system disease
- cardiovascular disease
- autonomic nervous system disease
- long term use of analgesic, sedative, and anti-anxiety drugs
- psychosis
- a patient with a language communication disorder not willing to cooperate with the experimenter
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: preoperative anxiety and butorphanol
preoperative anxiety scores of patients in Group A were >11 and received an intravenous loading dose of 15ug/kg butorphanol 5 min before starting the surgery, then followed by infusion of 7.5ug/kg/h butorphanol and stopped infusion until the Ramsay sedation score reached 4 points
|
intravenous loading dose of 15ug/kg butorphanol,and followed by infusion of 7.5ug/kg/h butorphanol and stopped infusion until the Ramsay sedation score reached 4 points
Other Names:
|
|
Placebo Comparator: preoperative anxiety and saline
preoperative anxiety scores of patients in Group B were >11 and received an infusion of the same volume of physiological saline
|
intravenous infusion of the same volume of physiological saline
|
|
Experimental: non-preoperative anxiety and butorphanol
preoperative anxiety scores of patients in Group C were ≤ 11 and received an intravenous loading dose of 15ug/kg butorphanol 5 min before starting the surgery, then followed by infusion of 7.5ug/kg/h butorphanol and stopped infusion until the Ramsay sedation score reached 4 points
|
intravenous loading dose of 15ug/kg butorphanol,and followed by infusion of 7.5ug/kg/h butorphanol and stopped infusion until the Ramsay sedation score reached 4 points
Other Names:
|
|
Placebo Comparator: non-preoperative anxiety and saline
preoperative anxiety scores of patients in Group D were ≤11 and received an infusion of the same volume of physiological saline
|
intravenous infusion of the same volume of physiological saline
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
preoperative anxiety score (Amsterdam preoperative anxiety and information scale, APAIS)
Time Frame: one day before the surgery
|
evaluate the preoperative anxiety score one day before the surgery, the scale ranges from 0-33.
And we define a score of 11 as a cut-off point, the higher the score the more serious the preoperative anxiety is
|
one day before the surgery
|
|
Ramsay sedation score (Ramsay sedation scale, RSS)
Time Frame: during the surgery
|
evaluate the Ramsay sedation score 10 min after getting into the operation room and 5, 10, 15, 30min after infusion.
The Ramsay sedation scale ranges from 1-6. 1, anxious and agitated or restless or both; 2, cooperative, orientated, and tranquil; 3, responds to commands only; 4, brisk response to a light glabellar tap or auditory stimulus; 5, sluggish response to a light glabellar tap or auditory stimulus; and 6, no response to a light glabellar tap or auditory stimulus.
A sedative state with RSS 4 was considered as an adequate level of sedation
|
during the surgery
|
|
the time when Ramsay sedation score reached 4 points
Time Frame: Ramsay sedation score reach 4 points during the surgery
|
record the time when Ramsay sedation score reached 4 points.
The Ramsay sedation scale ranges from 1-6. 1, anxious and agitated or restless or both; 2, cooperative, orientated, and tranquil; 3, responds to commands only; 4, brisk response to a light glabellar tap or auditory stimulus; 5, sluggish response to a light glabellar tap or auditory stimulus; and 6, no response to a light glabellar tap or auditory stimulus.
A sedative state with RSS 4 was considered as an adequate level of sedation
|
Ramsay sedation score reach 4 points during the surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
vital signs
Time Frame: during the surgery
|
Record Mean Arterial Pressure(MAP)10 min after getting into the operation room and 5, 10, 15, 30min after infusion
|
during the surgery
|
|
The incidence of nausea/ vomiting, dizzy, bradycardia and hypotension
Time Frame: in the first day after the surgery
|
Investigate the incidence of nausea/ vomiting, dizzy, bradycardia and hypotension in the first day after the surgery
|
in the first day after the surgery
|
|
post-operative visual analgesia scale scores (VAS)
Time Frame: within 24 hours after the surgery
|
investigate the VAS every hour till 6 hours and then every 2 hours till 24 hours.
The VAS ranges from 1-10.
0 means painless; 1-3 means mild pain; 4-6 means moderate pain and 7-10 means severe pain
|
within 24 hours after the surgery
|
|
Vital signs
Time Frame: during the surgery
|
Record Spo2 10 min after getting into the operation room and 5, 10, 15, 30min after infusion
|
during the surgery
|
|
Vital signs
Time Frame: during the surgery
|
Record Heart Rate(HR) 10 min after getting into the operation room and 5, 10, 15, 30min after infusion
|
during the surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Junchao Zhu, professor, Shengjing Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2017
Primary Completion (Actual)
December 20, 2018
Study Completion (Actual)
December 31, 2018
Study Registration Dates
First Submitted
January 13, 2019
First Submitted That Met QC Criteria
January 17, 2019
First Posted (Actual)
January 18, 2019
Study Record Updates
Last Update Posted (Actual)
January 18, 2019
Last Update Submitted That Met QC Criteria
January 17, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Effect of butorphanol
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.